Literature DB >> 19752385

The functional intraoperative pulmonary blood flow study is a more sensitive predictor than preoperative anatomy for right ventricular pressure and physiologic tolerance of ventricular septal defect closure after complete unifocalization in patients with pulmonary atresia, ventricular septal defect, and major aortopulmonary collaterals.

Osami Honjo1, Osman O Al-Radi, Cathy MacDonald, Kim-Chi D Tran, Priya Sapra, Lisa D Davey, Rajiu R Chaturvedi, Christopher A Caldarone, Glen S Van Arsdell.   

Abstract

BACKGROUND: The objective was to determine if intraoperative pulmonary artery (PA) flow studies after complete unifocalization correlate with postrepair hemodynamics for pulmonary atresia (PA), ventricular septal defects (VSD), and major aortopulmonary collaterals. METHODS AND
RESULTS: Twenty patients (median age, 8 months; weight, 7.9 kg) underwent unifocalization between 2003 and 2008. A functional PA flow study was achieved by cannulating the unifocalized central PA before intracardiac repair and increasing flow incrementally to 2.5 L/min per m(2). Mean PA pressure (mPAP) was measured. The intent was to close the VSD for a mPAP of <30 mm Hg. Right ventricular systolic pressure (RVSP) and systemic systolic pressure were recorded. Total incorporated pulmonary segments, pulmonary segment artery ratio (ratio of incorporated segments to 18), and total neopulmonary artery index (the sum of major aortopulmonary collaterals and native PA index) were calculated. The VSD was successfully closed in 18 patients (90%). One attempted closure required an intraoperative fenestration. The study mPAP correlated with RVSP (rho=0.72; P=0.0027) and RVSP/systemic systolic pressure (rho=0.67; P=0.0063). Total neopulmonary artery index had a nonsignificant negative correlation with RVSP (rho=-0.42; P=0.079). Total incorporated pulmonary segments and pulmonary segment artery ratio were not correlated. Flow study mPAP had the highest accuracy in predicting successful VSD closure: area under the receiver-operator curve (0.83) versus total neopulmonary artery index (0.42), pulmonary segments (0.35), and pulmonary segment artery ratio (0.33).
CONCLUSIONS: The intraoperative pulmonary flow study predicted postoperative physiology significantly better than did standard anatomic measures. Conventional measures should be used with caution when determining the possibility for complete repair.

Entities:  

Mesh:

Year:  2009        PMID: 19752385     DOI: 10.1161/CIRCULATIONAHA.108.844084

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

Review 1.  Surgical strategies for pulmonary atresia with ventricular septal defect associated with major aortopulmonary collateral arteries.

Authors:  Akio Ikai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-25

2.  Pulmonary Atresia with Ventricular Septal Defect and Major Aortopulmonary Collaterals Associated with Left Pulmonary Artery Interruption.

Authors:  Da-Na Mun; Chun Soo Park; Young-Hwue Kim; Hyun Woo Goo
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2016-10-05

3.  Identification of rare variants in novel candidate genes in pulmonary atresia patients by next generation sequencing.

Authors:  Xin Shi; Li Zhang; Kai Bai; Huilin Xie; Tieliu Shi; Ruilin Zhang; Qihua Fu; Sun Chen; Yanan Lu; Yu Yu; Kun Sun
Journal:  Comput Struct Biotechnol J       Date:  2020-02-12       Impact factor: 7.271

4.  Surgical Strategies and Results for Repair of Pulmonary Atresia with Ventricular Septal Defect and Major Aortopulmonary Collaterals: Experience of a Single Tertiary Center.

Authors:  Sertac Haydin; Serhat Bahadır Genç; Erkut Ozturk; Okan Yıldız; Mustafa Gunes; Ibrahim Cansaran Tanidir; Alper Guzeltas
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01

5.  Verifying the Usefulness of Pulmonary Blood Flow Studies in the Correction of Pulmonary Atresia and Ventricular Septal Defect with Major Aortopulmonary Collateral Arteries.

Authors:  Zirou Huang; Fan Cao; Rongjun Zou; Minghui Zou; Weidan Chen; Wenlei Li; Guodong Huang; Li Ma; Xinxin Chen
Journal:  Cardiol Res Pract       Date:  2021-07-24       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.